日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The statistical software revolution in pharmaceutical development: challenges and opportunities in open source

统计软件在药物研发领域的革命:开源软件带来的挑战与机遇

Sabanés Bové, Daniel; Seibold, Heidi; Boulesteix, Anne-Laure; Manitz, Juliane; Gasparini, Alessandro; Günhan, Burak K; Boix, Oliver; Schüler, Armin; Fillinger, Sven; Nahnsen, Sven; Jacob, Anna E; Jaki, Thomas

Elucidating the Structure and the Impact of Synthesis Methods on the Flexibility of the Metal-Organic Framework MIL-88 A (Fe) During Water Capture

阐明合成方法对金属有机框架MIL-88 A (Fe)在水捕获过程中柔性的影响及其结构特征

Manitz, Timo; Heck, Fabian; Rezeki, Sri; Gjorgjevikj, Kristina; Tokuda, Shun; Bette, Sebastian; Canossa, Stefano; Leistenschneider, Desirée; Krause, Simon

Avelumab first-line maintenance for advanced urothelial carcinoma: long-term outcomes from the JAVELIN Bladder 100 trial in older patients

Avelumab一线维持治疗晚期尿路上皮癌:JAVELIN Bladder 100试验中老年患者的长期疗效

Gupta, S; Climent Duran, M A; Sridhar, S S; Powles, T; Bellmunt, J; Park, S H; Gurney, H; Tsuchiya, N; Petrylak, D P; Tomita, Y; di Pietro, A; Manitz, J; Tyroller, K; Hoffman, J; Jacob, N; Grivas, P

A co-culture system to study the effects of Poly I:C-activated microglia on the differentiation of murine primary neural stem cells.

建立共培养系统,研究 Poly I:C 激活的小胶质细胞对小鼠原代神经干细胞分化的影响。

Manitz Marie Pierre, Violou Karina, Hedstück Malin, Bösing Kimberly, Kottmann Maria, Freund Nadja, Juckel Georg

Avelumab first-line maintenance in advanced urothelial carcinoma: Complete screening for prognostic and predictive factors using machine learning in the JAVELIN Bladder 100 phase 3 trial

Avelumab一线维持治疗晚期尿路上皮癌:在JAVELIN Bladder 100 III期试验中利用机器学习对预后和预测因素进行全面筛查

Manitz, Juliane; Gerhold-Ay, Aslihan; Kieslich, Pascal; Shah, Parantu; Mrowiec, Thomas; Tyroller, Karin

Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival

比较使用RECIST 1.1和irRECIST进行肿瘤评估的结果,以及与总生存期的关联

Manitz, Juliane; D'Angelo, Sandra P; Apolo, Andrea B; Eggleton, S Peter; Bajars, Marcis; Bohnsack, Oliver; Gulley, James L

Long-term avelumab in advanced non-small-cell lung cancer: summaries and post hoc analyses from JAVELIN Solid Tumor

阿维鲁单抗在晚期非小细胞肺癌中的长期应用:来自 JAVELIN 实体瘤研究的总结和事后分析

Hrinczenko, Borys; Iannotti, Nicholas; Goel, Sanjay; Spigel, David; Safran, Howard; Taylor, Matthew H; Bennouna, Jaafar; Wong, Deborah J; Kelly, Karen; Verschraegen, Claire; Bajars, Marcis; Manitz, Juliane; Ruisi, Mary; Gulley, James L

Sensor-based localization of epidemic sources on human mobility networks

基于传感器的流行病源在人类流动网络中的定位

Li, Jun; Manitz, Juliane; Bertuzzo, Enrico; Kolaczyk, Eric D

Poly I:C-induced maternal immune challenge reduces perineuronal net area and raises spontaneous network activity of hippocampal neurons in vitro

Poly I:C 诱导的母体免疫挑战减少了神经元周围网络面积并提高了体外海马神经元的自发网络活动

David Wegrzyn, Marie-Pierre Manitz, Michael Kostka, Nadja Freund, Georg Juckel, Andreas Faissner

Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis

在 Ib 期 JAVELIN 实体瘤研究中,Avelumab 作为二线疗法用于铂类药物治疗的转移性尿路上皮癌:2 年更新的疗效和安全性分析

Apolo, Andrea B; Ellerton, John A; Infante, Jeffrey R; Agrawal, Manish; Gordon, Michael S; Aljumaily, Raid; Gourdin, Theodore; Dirix, Luc; Lee, Keun-Wook; Taylor, Matthew H; Schöffski, Patrick; Wang, Ding; Ravaud, Alain; Manitz, Juliane; Pennock, Gregory; Ruisi, Mary; Gulley, James L; Patel, Manish R